Emotion regulation pathways (None established; commonly referred to as "ER pathways" in literature, but no standardized abbreviation.)

Emotion regulation pathways refer collectively to distributed neural circuits involving multiple interconnected brain regions, primarily including the prefrontal cortex (PFC), amygdala, anterior cingulate cortex (ACC), insula, limbic system structures, and associated neurotransmitter systems such as serotonin, dopamine, and norepinephrine transporters/receptors[1][2][3]. These circuits mediate both conscious ("top-down") cognitive strategies—like cognitive reappraisal—and unconscious ("bottom-up") automatic processes that shape how individuals experience and express emotions in response to internal or external stimuli. The PFC exerts executive control over subcortical structures like the amygdala during explicit emotion regulation tasks; conversely, bottom-up signals from limbic areas can drive emotional responses that require regulatory intervention from higher cortical centers[2][4]. Genetic factors influencing key neurotransmitters further modulate individual differences in regulatory capacity. Dysfunction across these distributed networks is implicated in various psychiatric disorders characterized by poor emotional control—including depression and anxiety—and thus represents an area of therapeutic interest at the circuit level rather than through direct molecular targeting[1]. “The neural mechanisms underlying emotional regulation involve key brain regions including the prefrontal cortex...amygdala...anterior cingulate cortex...and insula....Emotional reactions can be influenced by genetic polymorphisms...in genes encoding neurotransmitter systems such as norepinephrine..., dopamine...,and serotonin...” [1]

Other names

Emotional regulation circuitsNeural mechanisms of emotion regulationER pathways

Not applicable for the pathway itself. For drugs affecting related neurotransmitter systems: Modulation of serotonin reuptake (e.g., SSRIs), dopamine receptor agonism/antagonism, and norepinephrine reuptake inhibition. These mechanisms influence activity within key brain regions implicated in emotion processing and control.